Latigo Biotherapeutics, Inc. - 10-Q Filing
Latigo Biotherapeutics reports Q3 2026 results following August IPO and significant changes in equity structure.
Tickers: $LTGO
More Regulatory news
- AUDIOEYE INC - 10-Q Filing
- ROCKWELL AUTOMATION, INC - 10-K Filing
- United KSK Corp - 10-Q Filing
- AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing
- VIVIC CORP. - 10-K Filing
- WOLVERINE WORLD WIDE INC /DE/ - 10-Q Filing
- BlueOne Technologies, Inc. - 10-Q Filing
- Newton Golf Company, Inc. - 10-Q Filing
- XBiotech Inc. - 10-Q Filing
- Cohen & Co Inc. - 10-Q Filing